- Home
- XERS vs PLTK Comparison
XERS vs PLTK Comparison
Compare XERS & PLTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | PLTK |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.4B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XERS | PLTK |
|---|---|---|
| Price | $6.16 | $3.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $10.83 | $5.04 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.46% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $49,590,000.00 | ★ $2,755,400,000.00 |
| Revenue This Year | $34.37 | $2.60 |
| Revenue Next Year | $22.86 | $2.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.67 | 8.08 |
| 52 Week Low | $4.26 | $2.64 |
| 52 Week High | $10.08 | $5.59 |
Technical Indicators
Market Signals| Indicator | XERS | PLTK |
|---|---|---|
| Relative Strength Index (RSI) | 53.84 | 64.39 |
| Support Level | $5.79 | $3.56 |
| Resistance Level | $6.41 | $3.79 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 57.74 | 92.62 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.